Skip to main content
Clinical Trials/CTRI/2020/11/029184
CTRI/2020/11/029184Completed未知

Comparison of Efficacy and Cognitive Side Effect Profile Between Right Unilateral and Bilateral Ultra Brief Pulse ECT and Serum BDNF as Biomarker of Response in Schizophrenia: A Case Control Study

Dr Sukriti Mukherjee0 sites60 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • i)Patients of either Sex aged between 18-60 years.
  • ii)Right handed patients as assessed by Sidedness Bias Schedule (Mandal et al., 1992)
  • iii)Diagnosis of Schizophrenia (F20.0 to F20.9) according to ICD 10, having clinical indication for Electroconvulsive therapy.
  • iv)Patients giving written informed Consent.

Exclusion Criteria

  • i)Patients having predominant Catatonic symptoms
  • ii)Any other Psychiatric comorbidity
  • iii)Significant Neurological or Medical illness
  • iv)Female patients who are Pregnant during the study period.
  • v)Patients using any psychoactive substances in dependence pattern. (Except Caffeine and Nicotine)
  • vi)Patients on Clozapine

Investigators

Sponsor
Dr Sukriti Mukherjee

Similar Trials